Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
CLYM$10.19-0.35(-3.32%)Climb Bio Presents Initial PrisMN Phase 2 Data from Budoprutug in pMN at an Oral Session at ASN Kidney Week 2026[7:30:00 PM ET]TECK$59.05+0.15(+0.25%)Teck Provides Update on Highland Valley Copper Operations[3:18:56 PM ET]AXON$422.00+7.40(+1.78%)Axon Announces Body 5: Next-Generation Camera Built for the AI Era Axon (Nasdaq: AXON), the global leader in public safety technology, today announced Axon Body 5, its newest body-worn camera designed to bring more...[1:00:00 PM ET]PFE$30.02-0.40(-1.31%)Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026[11:18:00 AM ET]BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]
News desk

Live news

Stock news, press releases, and legal notices, with ticker, type, source, and time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as each headline is ingested.

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
FCEL Legal FuelCell Energy, Inc. Class Action Reminder – Robbins LLP Encourages FCEL Investors to Contact the Firm for Information About Their Rights GlobeNewswire
AMGN Stock news Amgen's IMDELLTRA Cuts Death Risk 58% in Small-Cell Lung Cancer Study MarketBeat
UNCY Legal UNCY DEADLINE NOTICE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Unicycive Therapeutics, Inc. Investors to Secure Counsel Before Important November 2 Deadline in Securities Class Action - UNCY GlobeNewswire
EXEL Stock news Forget the FDA Delay: 3 Reasons Exelixis Is Still a Buy The Motley Fool
MRNA Stock news Moderna, Inc. (MRNA) Discusses Phase III Data for Intismeran and Advances in Cancer Immunotherapy Transcript Seeking Alpha
BIDU Legal Baidu, Inc. Class Action Reminder – Robbins LLP Encourages BIDU Investors to Contact the Firm for Information About Their Rights GlobeNewswire
BKNG Stock news Booking vs. Chewy: Do Pet Treats or Plane Tickets Make for a Better Stock in 2026? The Motley Fool
ASTS Legal AST SpaceMobile, Inc. Class Action Reminder - Robbins LLP Encourages ASTS Investors to Contact the Firm for Information About Their Rights GlobeNewswire
APP Legal Shareholders of AppLovin Corporation (APP): Protect Your Rights Before November 16, 2026 – Contact Levi & Korsinsky ACCESS Newswire
UNCY Legal Securities Fraud Class Action Filed Against Unicycive Therapeutics, Inc. (UNCY) – Levi & Korsinsky Reminds Investors of November 2, 2026 ACCESS Newswire
CC Legal December 7, 2026 Deadline: Join Class Action Lawsuit Against The Chemours Company (CC) – Contact Levi & Korsinsky ACCESS Newswire
COMP Legal Class Action Filed Against Compass, Inc (COMP) Over Securities Violations – Contact Levi & Korsinsky Today ACCESS Newswire
BULL Legal Securities Class Action Lawsuit Filed Against Webull Corporation (BULL) – Levi & Korsinsky Represents Shareholders ACCESS Newswire
MRP Legal Investors in Millrose Properties, Inc. (MRP): Protect Your Rights – Contact Levi & Korsinsky Before December 8, 2026 ACCESS Newswire
PZZA Legal November 2, 2026 Deadline Approaching: Join Class Action Against Papa John's International, Inc. (PZZA) – Contact Levi & Korsinsky ACCESS Newswire
ARDX Legal Shareholders of Ardelyx, Inc. (ARDX): Protect Your Rights Before November 16, 2026 – Contact Levi & Korsinsky ACCESS Newswire
YSS Legal Investors in York Space Systems Inc (YSS): Protect Your Rights – Contact Levi & Korsinsky Before October 30, 2026 ACCESS Newswire
LINC Legal Investors in Lincoln Educational Services Corporation (LINC): Protect Your Rights – Contact Levi & Korsinsky Before November 10, 2026 ACCESS Newswire
RYDE Legal Investors in Ryde Group Ltd (RYDE): Protect Your Rights – Contact Levi & Korsinsky Before November 11, 2026 ACCESS Newswire
QBTS Legal Lost Money on D-Wave Quantum Inc. (QBTS)? Urged to Join Class Action Before December 15, 2026 – Contact Levi & Korsinsky ACCESS Newswire
Market Pulse

The same desk, in your inbox.

Market Pulse picks three headlines from the day, names the stock that moved, and shows the call that returns each one.

Monday, Wednesday, and Friday. Unsubscribe from any issue, or from account settings if you have one.

FAQ

Frequently asked questions

Is the live news desk the same feed as the API?
The desk shows the same articles in the browser: ticker, type, source, and published time. Signed-out visitors and Free accounts see the last year, 15 minutes behind. Pro, including the 7-day trial, sees the full archive as soon as a row is ingested. A Free API key returns the last year. Pro keys search the full archive and also include the summary and the original URL.
Why is the live news desk delayed?
Signed-out visitors and Free accounts see this desk 15 minutes behind ingestion, across the last year of headlines. Pro, including the 7-day trial, sees the full archive as soon as headlines are ingested. A Free API key has the same 15-minute delay. The delay is the plan, not an outage, and the status page stays green while the delayed view is on.
How far back does the live news desk go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices, 15 minutes behind ingestion. Pro, including the 7-day trial, sees the full archive as new rows are ingested. Page size is 20. A Free API key returns the last year. Pro keys search the full archive.
How do I see stock news without the 15-minute delay?
Start the 7-day Pro trial and sign in. A card is required. Pro is $15 a month, or $162 a year, and this desk then shows the full archive as headlines are ingested. Signed-out visitors and Free accounts still see the last year of headlines 15 minutes behind. A Free API key stays at 100 requests a day, the same delay, and the last year. One trial per email.
What do the columns on the news desk mean?
Ticker is the symbol attached to the article. Type is stock news, press release, or legal. Headline is the title. Source is the publisher or wire. Published is the article time in Eastern Time. Page size is 20. Use the type buttons when you want wires only, or legal notices kept out of the list.
Can I search the live news desk by ticker?
Yes. The desk has a ticker search, a headline search, a source menu, and buttons for stock news, press releases, and legal notices. Those filters stay on this page. The same filters exist on GET /v1/news if you want the JSON, including the summary and the original URL. Page size on the desk is 20.
How often do new stock headlines appear?
Sources are polled every second, including nights and weekends. Pro, including the 7-day trial, sees a row as soon as it is ingested. Signed-out visitors and Free accounts see that same row 15 minutes later. The desk is a browser view of the API feed, not a second dataset.